What makes the hepatitis C virus evolve?
Polymorphisms in the IFNL4 gene that affect both the presence and the form of the coded protein are associated with changes in the hepatitis C virus.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
eLife - 8(2019) vom: 03. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Brien, Thomas R [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.04.2020 Date Revised 28.01.2021 published: Electronic CommentOn: Elife. 2019 Sep 03;8:. - PMID 31478832 Citation Status MEDLINE |
|---|
| doi: |
10.7554/eLife.50148 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300880316 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300880316 | ||
| 003 | DE-627 | ||
| 005 | 20231225103450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7554/eLife.50148 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1002.xml |
| 035 | |a (DE-627)NLM300880316 | ||
| 035 | |a (NLM)31478837 | ||
| 035 | |a (PII)e50148 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Brien, Thomas R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What makes the hepatitis C virus evolve? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.04.2020 | ||
| 500 | |a Date Revised 28.01.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentOn: Elife. 2019 Sep 03;8:. - PMID 31478832 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Polymorphisms in the IFNL4 gene that affect both the presence and the form of the coded protein are associated with changes in the hepatitis C virus | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Hepatitis C | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a host-pathogen interactions | |
| 650 | 4 | |a human | |
| 650 | 4 | |a infectious disease | |
| 650 | 4 | |a innate immunity | |
| 650 | 4 | |a interferon-lambda 4 | |
| 650 | 4 | |a microbiology | |
| 650 | 4 | |a virus | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Interleukins |2 NLM | |
| 650 | 7 | |a Interferons |2 NLM | |
| 650 | 7 | |a 9008-11-1 |2 NLM | |
| 700 | 1 | |a Hartmann, Rune |e verfasserin |4 aut | |
| 700 | 1 | |a Prokunina-Olsson, Ludmila |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 8(2019) vom: 03. Sept. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2019 |g day:03 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.50148 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2019 |b 03 |c 09 | ||